Skip to main content
Top
Published in: AIDS and Behavior 1/2016

01-01-2016 | Original Paper

The ‘Fears’ of Disclosing HIV Status to Sexual Partners: A Mixed Methods Study in a Counseling Setting in Ghana

Authors: D. Obiri-Yeboah, D. Amoako-Sakyi, I. Baidoo, A. Adu-Oppong, T. Rheinländer

Published in: AIDS and Behavior | Issue 1/2016

Login to get access

Abstract

Encouraging disclosure within a trusting and supportive environment is imperative in dealing with HIV/AIDS related stigma. However, disclosure rates and the factors that influence it are vaguely understood in African societies. This study aimed at determining the disclosure rate and factors that influence disclosure in Cape Coast, Ghana. In-depth interviews of 15 peer educators and a survey of 510 PLHIV were used in a mixed methods study design. Majority of the study participants (78.6 %) had disclosed their HIV positive status to their sexual partners. Although peer educators in this study portrayed the overall outcome of disclosure to be negative, 84.0 % of disclosers were accepted by their partners without negative consequences after disclosure. This study suggests that the existing support services ill prepares newly diagnosed HIV positive clients and hampers disclosure initiatives. Providing comprehensive support services and re-training peer educators may be crucial in creating a safe disclosure environment in Ghana.
Literature
1.
go back to reference Dunkle KL, Stephenson R, Karita E, Chomba E, Kayitenkore K, Vwalika C, et al. New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data. Lancet. 2008;371(9631):2183–91.PubMedCrossRef Dunkle KL, Stephenson R, Karita E, Chomba E, Kayitenkore K, Vwalika C, et al. New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data. Lancet. 2008;371(9631):2183–91.PubMedCrossRef
2.
go back to reference Were WA, Mermin JH, Wamai N, Awor AC, Bechange S, Moss S, et al. Undiagnosed HIV infection and couple HIV discordance among household members of HIV-infected people receiving antiretroviral therapy in Uganda. J. Acquir Immune Defic Syndr. (1999). 2006;43(1):91–5. Were WA, Mermin JH, Wamai N, Awor AC, Bechange S, Moss S, et al. Undiagnosed HIV infection and couple HIV discordance among household members of HIV-infected people receiving antiretroviral therapy in Uganda. J. Acquir Immune Defic Syndr. (1999). 2006;43(1):91–5.
3.
go back to reference Lingappa JR, Lambdin B, Bukusi EA, Ngure K, Kavuma L, Inambao M, et al. Regional differences in prevalence of HIV-1 discordance in Africa and enrollment of HIV-1 discordant couples into an HIV-1 prevention trial. PLoS ONE. 2008;3(1):e1411.PubMedPubMedCentralCrossRef Lingappa JR, Lambdin B, Bukusi EA, Ngure K, Kavuma L, Inambao M, et al. Regional differences in prevalence of HIV-1 discordance in Africa and enrollment of HIV-1 discordant couples into an HIV-1 prevention trial. PLoS ONE. 2008;3(1):e1411.PubMedPubMedCentralCrossRef
4.
go back to reference Nacp G. National HIV Prevalence & AIDS Estimates Report 2012–2016. Accra, Ghana: Ministry of Health Accra; 2013. Nacp G. National HIV Prevalence & AIDS Estimates Report 2012–2016. Accra, Ghana: Ministry of Health Accra; 2013.
5.
go back to reference Firnhaber C, Westreich D, Schulze D, Williams S, Siminya M, Michelow P, et al. Highly active antiretroviral therapy and cervical dysplasia in HIV-positive women in South Africa. J Int AIDS Soc. 2012;15(2):17382.PubMedPubMedCentralCrossRef Firnhaber C, Westreich D, Schulze D, Williams S, Siminya M, Michelow P, et al. Highly active antiretroviral therapy and cervical dysplasia in HIV-positive women in South Africa. J Int AIDS Soc. 2012;15(2):17382.PubMedPubMedCentralCrossRef
6.
go back to reference McKenzie KP, Rogers RK, Njoroge JW, John-Stewart G, Richardson BA, Mugo NR, et al. Cervical squamous intraepithelial lesions among HIV-positive women on antiretroviral therapy in Kenya. Curr HIV Res. 2011;9(3):180–5.PubMedCrossRef McKenzie KP, Rogers RK, Njoroge JW, John-Stewart G, Richardson BA, Mugo NR, et al. Cervical squamous intraepithelial lesions among HIV-positive women on antiretroviral therapy in Kenya. Curr HIV Res. 2011;9(3):180–5.PubMedCrossRef
8.
go back to reference Bajunirwe F, Arts EJ, Tisch DJ, King CH, Debanne SM, Sethi AK. Adherence and treatment response among HIV-1-infected adults receiving antiretroviral therapy in a rural government hospital in Southwestern Uganda. J Int Assoc Phys. AIDS Care (Chicago, Ill : 2002). 2009;8(2):139–47. Bajunirwe F, Arts EJ, Tisch DJ, King CH, Debanne SM, Sethi AK. Adherence and treatment response among HIV-1-infected adults receiving antiretroviral therapy in a rural government hospital in Southwestern Uganda. J Int Assoc Phys. AIDS Care (Chicago, Ill : 2002). 2009;8(2):139–47.
9.
go back to reference Birbeck GL, Chomba E, Kvalsund M, Bradbury R, Mang’ombe C, Malama K, et al. Antiretroviral adherence in rural Zambia: the first year of treatment availability. Am J Trop Med Hyg. 2009;80(4):669–74.PubMed Birbeck GL, Chomba E, Kvalsund M, Bradbury R, Mang’ombe C, Malama K, et al. Antiretroviral adherence in rural Zambia: the first year of treatment availability. Am J Trop Med Hyg. 2009;80(4):669–74.PubMed
10.
go back to reference Hays RB, McKusick L, Pollack L, Hilliard R, Hoff C, Coates TJ. Disclosing HIV seropositivity to significant others. AIDS (London, England). 1993;7(3):425–31. Hays RB, McKusick L, Pollack L, Hilliard R, Hoff C, Coates TJ. Disclosing HIV seropositivity to significant others. AIDS (London, England). 1993;7(3):425–31.
11.
go back to reference Ssali SN, Atuyambe L, Tumwine C, Segujja E, Nekesa N, Nannungi A, et al. Reasons for disclosure of HIV status by people living with HIV/AIDS and in HIV care in Uganda: an exploratory study. AIDS Patient Care STDs. 2010;24(10):675–81.PubMedPubMedCentralCrossRef Ssali SN, Atuyambe L, Tumwine C, Segujja E, Nekesa N, Nannungi A, et al. Reasons for disclosure of HIV status by people living with HIV/AIDS and in HIV care in Uganda: an exploratory study. AIDS Patient Care STDs. 2010;24(10):675–81.PubMedPubMedCentralCrossRef
12.
go back to reference Gordon CM, Forsyth AD, Stall R, Cheever LW. Prevention interventions with persons living with HIV/AIDS: state of the science and future directions. AIDS Educ Prev. 2005;17(1 Suppl A):6–20. Gordon CM, Forsyth AD, Stall R, Cheever LW. Prevention interventions with persons living with HIV/AIDS: state of the science and future directions. AIDS Educ Prev. 2005;17(1 Suppl A):6–20.
13.
go back to reference Chkhartishvili N, Sharvadze L, Chokoshvili O, Bolokadze N, Rukhadze N, Kempker RR, et al. Mortality and causes of death among HIV-infected individuals in the country of Georgia: 1989–2012. AIDS research and human retroviruses. 2014. Chkhartishvili N, Sharvadze L, Chokoshvili O, Bolokadze N, Rukhadze N, Kempker RR, et al. Mortality and causes of death among HIV-infected individuals in the country of Georgia: 1989–2012. AIDS research and human retroviruses. 2014.
14.
go back to reference Kee MK, Lee JH, Kim EJ, Lee J, Nam JG, Yoo BH, et al. Improvement in survival among HIV-infected individuals in the Republic of Korea: need for an early HIV diagnosis. BMC Infect Dis. 2009;9:128.PubMedPubMedCentralCrossRef Kee MK, Lee JH, Kim EJ, Lee J, Nam JG, Yoo BH, et al. Improvement in survival among HIV-infected individuals in the Republic of Korea: need for an early HIV diagnosis. BMC Infect Dis. 2009;9:128.PubMedPubMedCentralCrossRef
15.
go back to reference Agaba PA, Digin E, Makai R, Apena L, Agbaji OO, Idoko JA, et al. Clinical characteristics and predictors of mortality in hospitalized HIV-infected Nigerians. J. Infect Dev Ctries. 2011. Agaba PA, Digin E, Makai R, Apena L, Agbaji OO, Idoko JA, et al. Clinical characteristics and predictors of mortality in hospitalized HIV-infected Nigerians. J. Infect Dev Ctries. 2011.
16.
go back to reference Koo K, Makin JD, Forsyth BWC. Where are the men? Targeting male partners in preventing mother-to-child HIV transmission. AIDS Care. 2013;25(1):43–8.PubMedCrossRef Koo K, Makin JD, Forsyth BWC. Where are the men? Targeting male partners in preventing mother-to-child HIV transmission. AIDS Care. 2013;25(1):43–8.PubMedCrossRef
17.
go back to reference Medley A, Garcia-Moreno C, McGill S, Maman S. Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: implications for prevention of mother-to-child transmission programmes. Bull World Health Organ. 2004;82(4):299–307.PubMedPubMedCentral Medley A, Garcia-Moreno C, McGill S, Maman S. Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: implications for prevention of mother-to-child transmission programmes. Bull World Health Organ. 2004;82(4):299–307.PubMedPubMedCentral
18.
go back to reference Villar-Loubet OM, Bruscantini L, Shikwane ME, Weiss S, Peltzer K, Jones DL. HIV disclosure, sexual negotiation and male involvement in prevention-of-mother-to-child- transmission in South Africa. Cult Health Sex. 2013;15(3):253–68.PubMedCrossRef Villar-Loubet OM, Bruscantini L, Shikwane ME, Weiss S, Peltzer K, Jones DL. HIV disclosure, sexual negotiation and male involvement in prevention-of-mother-to-child- transmission in South Africa. Cult Health Sex. 2013;15(3):253–68.PubMedCrossRef
19.
go back to reference Atashili J, Adimora AA, Ndumbe PM, Ikomey GM, Rinas AC, Myers E, et al. High prevalence of cervical squamous intraepithelial lesions in women on antiretroviral therapy in Cameroon: Is targeted screening feasible? Cancer Epidemiol. 2012;36(3):263–9.PubMedPubMedCentralCrossRef Atashili J, Adimora AA, Ndumbe PM, Ikomey GM, Rinas AC, Myers E, et al. High prevalence of cervical squamous intraepithelial lesions in women on antiretroviral therapy in Cameroon: Is targeted screening feasible? Cancer Epidemiol. 2012;36(3):263–9.PubMedPubMedCentralCrossRef
20.
go back to reference Groves AK, Maman S, Moodley D. HIV + women’s narratives of non-disclosure: resisting the label of immorality. Glob Pub Health. 2012;7(8):799–811.CrossRef Groves AK, Maman S, Moodley D. HIV + women’s narratives of non-disclosure: resisting the label of immorality. Glob Pub Health. 2012;7(8):799–811.CrossRef
21.
go back to reference Kgwete M. Beyond denial - women’s dilemmas and choices around HIV-testing, treatment and disclosure. Agenda. 2008;75(2):17–30. Kgwete M. Beyond denial - women’s dilemmas and choices around HIV-testing, treatment and disclosure. Agenda. 2008;75(2):17–30.
22.
go back to reference Olagbuji BN, Ezeanochie MC, Agholor KN, Olagbuji YW, Ande AB, Okonofua FE. Spousal disclosure of HIV serostatus among women attending antenatal care in urban Nigeria. J Obstet Gynaecol. 2011;31(6):486–8.PubMedCrossRef Olagbuji BN, Ezeanochie MC, Agholor KN, Olagbuji YW, Ande AB, Okonofua FE. Spousal disclosure of HIV serostatus among women attending antenatal care in urban Nigeria. J Obstet Gynaecol. 2011;31(6):486–8.PubMedCrossRef
23.
go back to reference Kielmann K, Cataldo F, Seeley J. Issues in the design of qualitative research. Introduction to qualitative research methodology 2011. p. 18–23. Kielmann K, Cataldo F, Seeley J. Issues in the design of qualitative research. Introduction to qualitative research methodology 2011. p. 18–23.
24.
go back to reference Green J, Thorogood N. Qualitative methods for health research. 3rd ed. Silverman D, editor. London: Sage; 2014. Green J, Thorogood N. Qualitative methods for health research. 3rd ed. Silverman D, editor. London: Sage; 2014.
25.
go back to reference Klave S, Brinkman S. Inter views: an introduction to qualitative research interviewing. London: Sage; 2009. Klave S, Brinkman S. Inter views: an introduction to qualitative research interviewing. London: Sage; 2009.
26.
go back to reference Guest G, MacQueen KM, Namey EE. Applied thematic analysis: Sage Publications; 2012. p. 295–xx. Guest G, MacQueen KM, Namey EE. Applied thematic analysis: Sage Publications; 2012. p. 295–xx.
27.
go back to reference Cresswell JW. Research design: qualitative, quantitative and mixed method approaches. Thousand Oaks: Sage; 2003. Cresswell JW. Research design: qualitative, quantitative and mixed method approaches. Thousand Oaks: Sage; 2003.
28.
go back to reference Ivankova NV, Creswell JW, Stick SL. Using mixed-methods sequential explanatory design: From theory to practice. Field Methods. 2006;18:3–20.CrossRef Ivankova NV, Creswell JW, Stick SL. Using mixed-methods sequential explanatory design: From theory to practice. Field Methods. 2006;18:3–20.CrossRef
29.
go back to reference Morse JM, Cheek J. Making room for qualitatively-driven mixed-method research. Qual Health Res. 2014;24(1):3–5.PubMedCrossRef Morse JM, Cheek J. Making room for qualitatively-driven mixed-method research. Qual Health Res. 2014;24(1):3–5.PubMedCrossRef
30.
go back to reference Loubiere S, Peretti-Watel P, Boyer S, Blanche J, Abega SC, Spire B. HIV disclosure and unsafe sex among HIV-infected women in Cameroon: results from the ANRS-EVAL study. Soc Sci Med. 2009;69(6):885–91.PubMedCrossRef Loubiere S, Peretti-Watel P, Boyer S, Blanche J, Abega SC, Spire B. HIV disclosure and unsafe sex among HIV-infected women in Cameroon: results from the ANRS-EVAL study. Soc Sci Med. 2009;69(6):885–91.PubMedCrossRef
32.
go back to reference Patel R, Ratner J, Gore-Felton C, Kadzirange G, Woelk G, Katzenstein D. HIV disclosure patterns, predictors, and psychosocial correlates among HIV positive women in Zimbabwe. AIDS Care. 2012;24(3):358–68.PubMedPubMedCentralCrossRef Patel R, Ratner J, Gore-Felton C, Kadzirange G, Woelk G, Katzenstein D. HIV disclosure patterns, predictors, and psychosocial correlates among HIV positive women in Zimbabwe. AIDS Care. 2012;24(3):358–68.PubMedPubMedCentralCrossRef
33.
go back to reference Mlambo M, Peltzer K. HIV sero-status disclosure and sexual behaviour among HIV positive patients who are on antiretroviral treatment (ART) in Mpumalanga, South Africa. J Hum Ecol. 2011;35(1):29–42. Mlambo M, Peltzer K. HIV sero-status disclosure and sexual behaviour among HIV positive patients who are on antiretroviral treatment (ART) in Mpumalanga, South Africa. J Hum Ecol. 2011;35(1):29–42.
34.
go back to reference Maiorana A, Koester KA, Myers JJ, Lloyd KC, Shade SB, Dawson-Rose C, et al. Helping patients talk about HIV: inclusion of messages on disclosure in prevention with positive interventions in clinical settings. AIDS Educ Prev. 2012;24(2):179–92.PubMedCrossRef Maiorana A, Koester KA, Myers JJ, Lloyd KC, Shade SB, Dawson-Rose C, et al. Helping patients talk about HIV: inclusion of messages on disclosure in prevention with positive interventions in clinical settings. AIDS Educ Prev. 2012;24(2):179–92.PubMedCrossRef
35.
go back to reference Seid M, Wasie B, Admassu M. Disclosure of HIV positive result to a sexual partner among adult clinical service users in Kemissie district, northeast Ethiopia. Afr J Reprod Health. 2012;16(1):97–104.PubMed Seid M, Wasie B, Admassu M. Disclosure of HIV positive result to a sexual partner among adult clinical service users in Kemissie district, northeast Ethiopia. Afr J Reprod Health. 2012;16(1):97–104.PubMed
36.
go back to reference Relf MV, Bishop TL, Lachat MF, Schiavone DB, Pawlowski L, Bialko MF, et al. A qualitative analysis of partner selection, HIV serostatus disclosure, and sexual behaviors among HIV-positive urban men. AIDS Educ Prev. 2009;21(3):280–97.PubMedCrossRef Relf MV, Bishop TL, Lachat MF, Schiavone DB, Pawlowski L, Bialko MF, et al. A qualitative analysis of partner selection, HIV serostatus disclosure, and sexual behaviors among HIV-positive urban men. AIDS Educ Prev. 2009;21(3):280–97.PubMedCrossRef
37.
go back to reference Moses S, Tomlinson M. The fluidity of disclosure: a longitudinal exploration of women’s experience and understanding of HIV disclosure in the context of pregnancy and early motherhood. AIDS Care. 2013;25(6):667–75.PubMedCrossRef Moses S, Tomlinson M. The fluidity of disclosure: a longitudinal exploration of women’s experience and understanding of HIV disclosure in the context of pregnancy and early motherhood. AIDS Care. 2013;25(6):667–75.PubMedCrossRef
38.
go back to reference Akumatey B. Gender norms, domestic violence, and women’s vulnerability to HIV/AIDS. In: Darkwa A, editor: Gender studies & human rights documentation centre; 2009. Akumatey B. Gender norms, domestic violence, and women’s vulnerability to HIV/AIDS. In: Darkwa A, editor: Gender studies & human rights documentation centre; 2009.
39.
go back to reference Bochow A. Sex and gender in an era of AIDS: Ghana at the turn of the millennium. J R Anthropol Inst. 2009;15(3):656–7.CrossRef Bochow A. Sex and gender in an era of AIDS: Ghana at the turn of the millennium. J R Anthropol Inst. 2009;15(3):656–7.CrossRef
40.
go back to reference Dako-Gyeke P. ‘Safe sex talk:’ negotiating safe sex practices in heterosexual relationships. Mediterr J Soc Sci. 2013;4(2):309–18. Dako-Gyeke P. ‘Safe sex talk:’ negotiating safe sex practices in heterosexual relationships. Mediterr J Soc Sci. 2013;4(2):309–18.
41.
go back to reference Jones DL, Peltzer K, Villar-Loubet O, Shikwane E, Cook R, Vamos S, et al. Reducing the risk of HIV infection during pregnancy among South African women: a randomized controlled trial. AIDS Care. 2013;25(6):702–9.PubMedPubMedCentralCrossRef Jones DL, Peltzer K, Villar-Loubet O, Shikwane E, Cook R, Vamos S, et al. Reducing the risk of HIV infection during pregnancy among South African women: a randomized controlled trial. AIDS Care. 2013;25(6):702–9.PubMedPubMedCentralCrossRef
Metadata
Title
The ‘Fears’ of Disclosing HIV Status to Sexual Partners: A Mixed Methods Study in a Counseling Setting in Ghana
Authors
D. Obiri-Yeboah
D. Amoako-Sakyi
I. Baidoo
A. Adu-Oppong
T. Rheinländer
Publication date
01-01-2016
Publisher
Springer US
Published in
AIDS and Behavior / Issue 1/2016
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-015-1022-1

Other articles of this Issue 1/2016

AIDS and Behavior 1/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.